Lund, S.E., August 12, 2024 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its fifth consecutive Silver Rating from EcoVadis, the world’s leading provider of business sustainability ratings. Of the 1.6 million companies evaluated by EcoVadis across diverse industries worldwide, TFS is honored to be in the top 15%, highlighting its unwavering commitment to corporate sustainability and its positive influence on the health sciences sector.
Aligned with their strong dedication to Environmental, Social, and Governance (ESG) principles, TFS demonstrates advanced management systems for ethics, labor and human rights, and environmental issues. By incorporating the EcoVadis rating into their ESG strategy, they continue to enhance their sustainability performance in a comprehensive manner.
The organization’s 2023 Sustainability Report details substantial advancements in environmental care, social responsibility, and sustainable business operations.
You can access the full report here.
Earlier this year, TFS also reported an improvement of its Carbon Disclosure Project (CDP) scoring from ‘D’ to ‘C,’ reflecting enhanced initiatives in managing environmental impact. The CDP, a global nonprofit, operates the world’s leading platform for environmental information disclosure. Additionally, TFS has committed to setting science-based targets with the Science Based Targets initiative (SBTi), further demonstrating its ambition to reduce its carbon footprint and support global climate goals.
“Receiving the Silver Rating from EcoVadis for the fifth year in a row validates our ongoing commitment to creating an ethical and sustainable business,” said Patrik Darsund, Chief People Officer at TFS. “We are proud of the progress we’ve made and continue to strive for significant contributions to the health sciences field and beyond.”
This achievement highlights TFS’s reliability and ethical practices, which are vital for building trust with its partners and clients. TFS’s sustainability efforts reflect the organization’s strong focus on transparency and accountability, assuring partners and clients of its integrity.
Learn more about how TFS HealthScience is paving the way for a sustainable future in clinical research.
About TFS HealthScience
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that supports biotechnology and pharmaceutical companies throughout their entire clinical development journey. In partnership with customers, we build solution-driven teams working towards a healthier future. Bringing together nearly 800+ professionals, TFS delivers tailored clinical research services in more than 40 countries with flexible clinical development and strategic resourcing solutions across key therapeutic areas, including Dermatology, Immunology & Inflammatory Diseases, Internal Medicine, Neuroscience, Oncology & Hematology, and Ophthalmology.
Detailed information about TFS and its business offerings can be obtained through www.tfscro.com